BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17121829)

  • 1. Visualization of aggregation of the Rnq1 prion domain and cross-seeding interactions with Sup35NM.
    Vitrenko YA; Gracheva EO; Richmond JE; Liebman SW
    J Biol Chem; 2007 Jan; 282(3):1779-87. PubMed ID: 17121829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro.
    Derkatch IL; Uptain SM; Outeiro TF; Krishnan R; Lindquist SL; Liebman SW
    Proc Natl Acad Sci U S A; 2004 Aug; 101(35):12934-9. PubMed ID: 15326312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased [PSI+] appearance by fusion of Rnq1 with the prion domain of Sup35 in Saccharomyces cerevisiae.
    Choe YJ; Ryu Y; Kim HJ; Seok YJ
    Eukaryot Cell; 2009 Jul; 8(7):968-76. PubMed ID: 19411620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion and nonprion amyloids: a comparison inspired by the yeast Sup35 protein.
    Kushnirov VV; Vishnevskaya AB; Alexandrov IM; Ter-Avanesyan MD
    Prion; 2007; 1(3):179-84. PubMed ID: 19164899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A regulatory role of the Rnq1 nonprion domain for prion propagation and polyglutamine aggregates.
    Kurahashi H; Ishiwata M; Shibata S; Nakamura Y
    Mol Cell Biol; 2008 May; 28(10):3313-23. PubMed ID: 18332119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the interactions of yeast prions: [SWI+], [PSI+], and [PIN+].
    Du Z; Li L
    Genetics; 2014 Jun; 197(2):685-700. PubMed ID: 24727082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous prion-forming proteins interact to cross-seed aggregation in Saccharomyces cerevisiae.
    Keefer KM; Stein KC; True HL
    Sci Rep; 2017 Jul; 7(1):5853. PubMed ID: 28724957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dynamics of in vitro amyloid fiber formation of yeast prion protein Sup35NM].
    Wei HY; Liu YX; Wang JW; Qu JG; Zhao WM; Yu XP; Hong T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):39-42. PubMed ID: 16642217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic polyglutamine tracts are potent inducers of spontaneous Sup35 and Rnq1 amyloidogenesis.
    Goehler H; Dröge A; Lurz R; Schnoegl S; Chernoff YO; Wanker EE
    PLoS One; 2010 Mar; 5(3):e9642. PubMed ID: 20224794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous aggregates promote de novo prion appearance via more than one mechanism.
    Arslan F; Hong JY; Kanneganti V; Park SK; Liebman SW
    PLoS Genet; 2015 Jan; 11(1):e1004814. PubMed ID: 25568955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsp104 binds to yeast Sup35 prion fiber but needs other factor(s) to sever it.
    Inoue Y; Taguchi H; Kishimoto A; Yoshida M
    J Biol Chem; 2004 Dec; 279(50):52319-23. PubMed ID: 15448141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion protein insertional mutations increase aggregation propensity but not fiber stability.
    Kalastavadi T; True HL
    BMC Biochem; 2008 Mar; 9():7. PubMed ID: 18366654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The physical dimensions of amyloid aggregates control their infective potential as prion particles.
    Marchante R; Beal DM; Koloteva-Levine N; Purton TJ; Tuite MF; Xue WF
    Elife; 2017 Sep; 6():. PubMed ID: 28880146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsense suppression in yeast cells overproducing Sup35 (eRF3) is caused by its non-heritable amyloids.
    Salnikova AB; Kryndushkin DS; Smirnov VN; Kushnirov VV; Ter-Avanesyan MD
    J Biol Chem; 2005 Mar; 280(10):8808-12. PubMed ID: 15618222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locating folds of the in-register parallel β-sheet of the Sup35p prion domain infectious amyloid.
    Gorkovskiy A; Thurber KR; Tycko R; Wickner RB
    Proc Natl Acad Sci U S A; 2014 Oct; 111(43):E4615-22. PubMed ID: 25313080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid properties of the yeast cell wall protein Toh1 and its interaction with prion proteins Rnq1 and Sup35.
    Sergeeva AV; Sopova JV; Belashova TA; Siniukova VA; Chirinskaite AV; Galkin AP; Zadorsky SP
    Prion; 2019 Jan; 13(1):21-32. PubMed ID: 30558459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperature dependence of the aggregation kinetics of Sup35 and Ure2p yeast prions.
    Sabaté R; Villar-Piqué A; Espargaró A; Ventura S
    Biomacromolecules; 2012 Feb; 13(2):474-83. PubMed ID: 22176525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo [PSI
    Sharma J; Wisniewski BT; Paulson E; Obaoye JO; Merrill SJ; Manogaran AL
    Sci Rep; 2017 Mar; 7(1):76. PubMed ID: 28250435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleation seed size determines amyloid clearance and establishes a barrier to prion appearance in yeast.
    Villali J; Dark J; Brechtel TM; Pei F; Sindi SS; Serio TR
    Nat Struct Mol Biol; 2020 Jun; 27(6):540-549. PubMed ID: 32367069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rnq1 protein protects [PSI^(+)] prion from effect of the PNM mutation].
    Bondarev SA; Likholetova DV; Belousov MV; Zhouravleva GA
    Mol Biol (Mosk); 2017; 51(2):367-371. PubMed ID: 28537243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.